MedMira (STU:47M) Total Stockholders Equity : €-11.00 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MedMira Total Stockholders Equity?

MedMira's Total Stockholders Equity for the quarter that ended in Jan. 2024 was €-11.00 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. MedMira's Book Value per Share for the quarter that ended in Jan. 2024 was €-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. MedMira's Debt-to-Equity for the quarter that ended in Jan. 2024 was -0.56.

MedMira Total Stockholders Equity Historical Data

The historical data trend for MedMira's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Total Stockholders Equity Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Total Stockholders Equity

Get a 7-Day Free Trial

-9.20

-10.03

-10.62

-9.39

-10.29

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Stockholders Equity	Get a 7-Day Free Trial															-9.32	-9.52	-10.29	-10.92	-11.00

MedMira (STU:47M) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

MedMira's Book Value per Share for the quarter that ended in Jan. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-10.998	-	0.002)	/	701.731
	=	-0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

MedMira's Debt-to-Equity for the quarter that ended in Jan. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.298	+	1.808)	/	-10.998
	=	-0.56

MedMira Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of MedMira's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (STU:47M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (STU:47M) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MMIRF:USA MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.

MedMira (STU:47M) Headlines

No Headlines